Stem cell therapy in multiple sclerosis / Mustafa Ibrahim Abdelaziz Emara ; Supervised Manal Fahmy , Nermin Adel Kishk
Material type:
- استخدام الخلايا الجذعية لعلاج مرض التصلب المتناثر للجهاز العصبى [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.21.M.Sc.2014.Mu.S (Browse shelf(Opens below)) | Not for loan | 01010110064350000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.21.M.Sc.2014.Mu.S (Browse shelf(Opens below)) | 64350.CD | Not for loan | 01020110064350000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.11.21.M.Sc.2014.Mo.P Prognostic value of clinical examination and somatoensory evoked potentials in coma due to stroke / | Cai01.11.21.M.Sc.2014.Mo.P Prognostic value of clinical examination and somatoensory evoked potentials in coma due to stroke / | Cai01.11.21.M.Sc.2014.Mu.S Stem cell therapy in multiple sclerosis / | Cai01.11.21.M.Sc.2014.Mu.S Stem cell therapy in multiple sclerosis / | Cai01.11.21.M.Sc.2014.Ne.Q The quality of life, depression and anxiety in mothers of children with mono-symptomatic primary nocturnal enuresis3 / | Cai01.11.21.M.Sc.2014.Ne.Q The quality of life, depression and anxiety in mothers of children with mono-symptomatic primary nocturnal enuresis3 / | Cai01.11.21.M.Sc.2014.No.E Event related potentials in bipolar disorder with co morbid anxiety disorder / |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Neuropsychiatry
HSCT and MSCT offer hope for a new effective treatment for MS. Recent trials of low intensity HSCT indicate that as researchers improve the conditioning protocol, they can significantlyreduce the adverse side effects without decreasing efficacy. Similarly, a recent clinical trial evaluating MSCT concluded it was a feasible and safe treatment method for MS patients. Given MSCT{u2019}s positive potential on neural restoration and immunomodulation demonstrated in animal models, MSCT offers a low risk/high reward treatment option for MS patients. Additionally, HSCT and MSCT could work synergistically to further decrease adverse side effects and increase patient outcomes
Issued also as CD
There are no comments on this title.